Hereditary Angioedema Drug Market

  • Published on 2025-11-03
  • Report Code: 1214
  • 170-350 pages
Hereditary Angioedema Drug Market

Hereditary Angioedema Drug Market: Segmented: By Type (C1 Esterase Inhibitor, Kallikrein Inhibitor, Selective Bradykinin B2 Receptor Antagonist), By Distribution Channel (Retail, Pharmacies, Hospital Pharmacies, Online Pharmacies), And Region - Global Analysis of Market Size, Share & Trends For 2019-2021 And Forecasts To 2031

Table Of Content

Content 

  1. Executive Summary
    1. Regional Market Share
    2. Business Trends
    3.  Global Hereditary Angioedema Drug Market: COVID-19 Outbreak
    4. Regional Trends
    5. Segmentation Snapshot
  2. Research Methodology
    1. Research Objective       
    2. Research Approach     
    3. Data Sourcing and Methodology              
    4. Primary Research        
    5. Secondary Research
      1.  Paid Sources
      2.  Public Sources             
    6. Market Size Estimation and Data Triangulation   
  3. Market Characteristics             
    1. Market Definition
    2. Global Hereditary Angioedema Drug Market: COVID-19 Impact
    3. Key Segmentations       
    4. Key Developments        
    5. Allied Industry Data
  4. Global Hereditary Angioedema Drug Market - Industry Insights
    1. Industry Segmentation
    2. COVID-19 overview on world economy
    3. Industry ecosystem Channel analysis
    4. Innovation & Sustainability
  5. Macroeconomic Indicators
  6. Recent Developments
  7. Market Dynamics        
    1. Introduction
    2. Growth Drivers
    3. Market Opportunities   
    4. Market Restraints
    5. Market Trends
  8. Risk Analysis
  9. Market Analysis
    1. Porters Five Forces
    2. PEST Analysis
      1. Political    
      2. Economic
      3. Social
      4. Technological
  10. Global Hereditary Angioedema Drug Market
    1. Overview
    2. Historical Analysis (2016-2020)
      1. Market Size, Y-o-Y Growth (%) and Market Forecast
  11. Global Hereditary Angioedema Drug Market Size & Forecast 2020A-2031F             
    1. Overview         
    2. Key Findings
    3. Market Segmentation
      1. By Type
        1. C1 Esterase Inhibitor
        2. By Value (USD Million) 2020-2031F
        3. Market Share (%) 2020-2031F
        4. Y-o-Y Growth (%) 2021-2031F
        5. Kallikrein Inhibitor
        6. By Value (USD Million) 2020-2031F
        7. Market Share (%) 2020-2031F
        8. Y-o-Y Growth (%) 2021-2031F
        9. Selective Bradykinin B2 Receptor Antagonist
        10. By Value (USD Million) 2020-2031F
        11. Market Share (%) 2020-2031F
        12. Y-o-Y Growth (%) 2021-2031F
      2. By Distribution Channel
        1. Retail Pharmacies
        2. By Value (USD Million) 2020-2031F
        3. Market Share (%) 2020-2031F
        4. Y-o-Y Growth (%) 2021-2031F
        5. Hospital Pharmacies
        6. By Value (USD Million) 2020-2031F
        7. Market Share (%) 2020-2031F
        8. Y-o-Y Growth (%) 2021-2031F
        9. Online Pharmacies
        10. By Value (USD Million) 2020-2031F
        11. Market Share (%) 2020-2031F
        12. Y-o-Y Growth (%) 2021-2031F
  12. North America Hereditary Angioedema Drug Market Size & Forecast 2020A-2031F
    1. Overview         
    2. Key Findings
    3. Market Segmentation
      1. By Type
      2. By Distribution Channel
    4. Country
      1. United States
      2. Canada
  13. Europe Hereditary Angioedema Drug Market Size & Forecast 2020A-2031F
    1. Overview         
    2. Key Findings
    3. Market Segmentation
      1. By Type
      2. By Distribution Channel
    4. Country
      1. Germany
      2. United Kingdom
      3. France
      4. Italy
      5. Russia
      6. Rest of Europe
  14. Asia Pacific Hereditary Angioedema Drug Market Size & Forecast 2020A-2031F
    1. Overview         
    2. Key Findings
    3. Market Segmentation
      1. By Type
      2. By Distribution Channel
    4. By Country
      1. India
      2. China
      3. Japan
      4. Rest of Asia Pacific
  15. Middle East and Africa Hereditary Angioedema Drug Market Size & Forecast 2020A-2031F
    1. Overview         
    2. Key Findings
    3. Market Segmentation
      1. By Type
      2. By Distribution Channel
    4. Country
      1. Saudi Arabia
      2. UAE
      3. Rest of Middle East and Africa
  16. Latin America Hereditary Angioedema Drug Market Size & Forecast 2020A-2031F
    1. Overview         
    2. Key Findings
    3. Market Segmentation
      1. By Type
      2. By Distribution Channel
    4. Country
      1. Mexico
      2. Brazil
      3. Argentina
      4. Rest of Latin America
  17. Competitive Landscape
    1. Company market share, 2020
    2. Key player overview
    3. Key stakeholders
  18. Company Profiles       
    1. Pharming Group NV
      1. Company Overview
      2. Financial Overview
      3. Key Product; Analysis
      4. Company Assessment          
        1. Product Portfolio        
        2. Key Clients
        3. Market Share              
        4. Recent News & Development (Last 3 Yrs.)         
        5. Executive Team
    2. Takeda
    3. CSL Limited
    4. IBio Inc.
    5. BioCryst Pharmaceuticals Inc.
    6. Ionis Pharmaceuticals Inc.
    7. Arrowhead Pharmaceuticals
    8. Adverum Biotechnologies
    9. Attune Pharmaceuticals, Inc.
    10. Other Prominent Players
  19. Appendix
  20. Consultant Recommendation
To request a free sample copy of this report, please complete the form below.

Select License Type

$ 4950

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at [email protected] with your request.

Read all reports

Our Clients

We have been working with some Fortune 500+ clients